Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04587128
Title Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Wisconsin, Madison

colorectal cancer



Cetuximab + Irinotecan


Irinotecan + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Wisconsin Carbone Cancer Center Recruiting Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from for the field